Chemung Financial (CHMG) EBITDA (2010 - 2026)

Chemung Financial (CHMG) has 17 years of EBITDA data on file, last reported at $22.3 million in Q1 2026.

• EBITDA for Q1 2026 came in at $22.3 million, up 11.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $69.6 million (down 15.68% YoY), and the FY2025 annual result was $67.3 million, down 21.04% from the prior year.
• EBITDA improved to $22.3 million in Q1 2026 per CHMG's latest filing, from $21.8 million in the prior quarter.
• Over five years, EBITDA peaked at $22.6 million in Q1 2024 and troughed at -$16.9 million in Q2 2022.
• A 5-year average of $7.4 million and a median of $19.9 million in 2025 frame the typical range for EBITDA.
• The sharpest annual moves came in 2023 and 2025: EBITDA soared 261.72% in 2023, then plunged 80.92% in 2025.
• A 5-year view of EBITDA shows it stood at -$15.1 million in 2022, then jumped by 214.42% to $17.3 million in 2023, then gained by 20.07% to $20.7 million in 2024, then advanced by 5.31% to $21.8 million in 2025, then gained by 1.87% to $22.3 million in 2026.
• Business Quant data shows CHMG's EBITDA at $22.3 million in Q1 2026, $21.8 million in Q4 2025, and $21.7 million in Q3 2025.